,,ii #aacth ,,congress #b;d ,session ,s4 #bedi ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,june #bf1 #bjad ,ms4 ,klobuchar 7for herself and ,mr4 ,mc,cain7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to amend the ,federal ,food1 ,drug1 and ,cosmetic ,act to allow for the personal importation of safe and affordable drugs from approved pharmacies in ,canada4 #a4 ,short title ,this ,act may be cited as the ,safe and ,affordable ,drugs from ,canada ,act of #bjad4 #b4 ,safe and affordable drugs from ,canada ,chapter ,,viii of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cha et seq47 is amended by adding at the end the following3 #haj4 ,importation by individuals of prescription drugs from ,canada 7a7 ,in general ,notwithstanding any other provision of this ,act1 not later than #ahj days after the date of enactment of this section1 the ,secretary shall promulgate regulations permitting individuals to safely import into the ,united ,states a prescription drug described in subsection 7b74 7b7 ,prescription drug ,a prescription drug described in this subsection-- 7#a7 is a prescription drug that-- 7,a7 is purchased from an approved ,canadian pharmacy2 7,b7 is dispensed by a pharmacist licensed to practice pharmacy and dispense prescription drugs in ,canada2 7,c7 is purchased for personal use by the individual1 not for resale1 in quantities that do not exceed a #ij-;day supply2 7,d7 is filled using a valid prescription issued by a physician licensed to practice in a ,state in the ,united ,states2 and 7,e7 has the same active ingredient or ingredients1 route of administration1 dosage form1 and strength as a prescription drug approved by the ,secretary under chapter ,v2 and 7#b7 does not include-- 7,a7 a controlled substance 7as defined in section #ajb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb772 7,b7 a biological product 7as defined in section #cea of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bfb772 7,c7 an infused drug 7including a peritoneal dialysis solution72 7,d7 an intravenously injected drug2 7,e7 a drug that is inhaled during surgery2 7,f7 a parenteral drug2 7,g7 a drug manufactured through #a or more biotechnology processes1 including-- 7i7 a therapeutic ,,dna plasmid product2 7ii7 a therapeutic synthetic peptide product of not more than #dj amino acids2 7iii7 a monoclonal antibody product for in vivo use2 and 7iv7 a therapeutic recombinant ,,dna-derived product2 7,h7 a drug required to be refrigerated at any time during manufacturing1 packing1 processing1 or holding2 or 7,i7 a photoreactive drug4 7c7 ,approved ,canadian pharmacy 7#a7 ,in general ,in this section1 an approved ,canadian pharmacy is a pharmacy that-- 7,a7 is located in ,canada2 and 7,b7 that the ,secretary certifies-- 7i7 is licensed to operate and dispense prescription drugs to individuals in ,canada2 and 7ii7 meets the criteria under paragraph 7#c74 7#b7 ,publication of approved canadian pharmacies ,the ,secretary shall publish on the ,internet ,web site of the ,food and ,drug ,administration a list of approved ,canadian pharmacies1 including the ,internet ,web site address of each such approved ,canadian pharmacy1 from which individuals may purchase prescription drugs in accordance with subsection 7a74 7#c7 ,additional criteria ,to be an approved ,canadian pharmacy1 the ,secretary shall certify that the pharmacy-- 7,a7 has been in existence for a period of at least #e years preceding the date of such certification and has a purpose other than to participate in the program established under this section2 7,b7 operates in accordance with pharmacy standards set forth by the provincial pharmacy rules and regulations enacted in ,canada2 7,c7 has processes established by the pharmacy1 or participates in another established process1 to certify that the physical premises and data reporting procedures and licenses are in compliance with all applicable laws and regulations1 and has implemented policies designed to monitor ongoing compliance with such laws and regulations2 7,d7 conducts or commits to participate in ongoing and comprehensive quality assurance programs and implements such quality assurance measures1 including blind testing1 to ensure the veracity and reliability of the findings of the quality assurance program2 7,e7 agrees that laboratories approved by the ,secretary shall be used to conduct product testing to determine the safety and efficacy of sample pharmaceutical products2 7,f7 has established1 or will establish or participate in1 a process for resolving grievances and will be held accountable for violations of established guidelines and rules2 7,g7 does not resell products from online pharmacies located outside ,canada to customers in the ,united ,states2 and 7,h7 meets any other criteria established by the ,secretary4 4